Related Experiment Video
Updated: May 14, 2026
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo
Siham Chaouche-Mazouni1, Marie-Christine Copin, Philippe Lassalle
1Department of Biology, Kouba High School, Algiers, Algeria.
Background:
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm with few treatment options. Reliable tumour cell lines for mesothelioma research are rare. Claudins seem to be attractive targets for cancer therapy.
Aim:
To establish a claudin-based MPM phenotype and to verify whether it is preserved in vitro and in vivo.
Materials And Methods:
Claudin-3 and -4 expression was examined by immunohistochemistry and immunoblotting in MPM (n=15) and lung adenocarcinoma (n=5) specimens. Claudin-3, -4 and -15 expression was also assessed in MPM versus adenocarcinoma cell lines and in MPM versus adenocarcinoma-derived tumour xenografts mouse models.
Results:
A defined MPM phenotype was established: M14K and M38K cell lines highly express Claudin-15 and calretinin but not claudin-3 nor claudin-4. Similar results were obtained in xenograft mouse models.
Conclusion:
M14K and M38K cell lines, whether in vitro or in an animal model are representative models and appropriate in exploring new therapeutic strategies in MPM that may target claudins.
Insights
New mesothelioma cell lines (M14K, M38K) highly express Claudin-15, offering valuable models for developing novel claudin-targeted cancer therapies for malignant pleural mesothelioma (MPM).
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited treatment options.
- The scarcity of reliable mesothelioma cell lines hinders research.
- Claudins represent promising therapeutic targets in cancer.
Purpose of the Study:
- To establish a claudin-based phenotype for malignant pleural mesothelioma (MPM).
- To confirm the in vitro and in vivo preservation of this phenotype.
Main Methods:
- Immunohistochemistry and immunoblotting were used to analyze claudin-3 and -4 expression in MPM and lung adenocarcinoma specimens.
- Claudin-3, -4, and -15 expression was assessed in cell lines and xenograft mouse models.
Main Results:
- A distinct MPM phenotype was identified, characterized by high expression of Claudin-15 and calretinin, but not claudin-3 or -4, in M14K and M38K cell lines.
- These findings were consistent in xenograft mouse models.
Conclusions:
- The M14K and M38K cell lines, both in vitro and in vivo, serve as representative models for MPM research.
- These models are suitable for exploring novel therapeutic strategies targeting claudins in MPM.
